SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cardlytics, Inc. – ‘8-K’ for 11/18/22

On:  Friday, 11/18/22, at 4:05pm ET   ·   For:  11/18/22   ·   Accession #:  1666071-22-155   ·   File #:  1-38386

Previous ‘8-K’:  ‘8-K’ on 11/14/22 for 11/8/22   ·   Next:  ‘8-K’ on / for 1/23/23   ·   Latest:  ‘8-K’ on / for 4/9/24   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/18/22  Cardlytics, Inc.                  8-K:8,9    11/18/22   11:1.4M

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     38K 
 2: EX-10.1     Material Contract                                   HTML   1.06M 
 7: R1          Document and Entity Information                     HTML     45K 
 9: XML         IDEA XML File -- Filing Summary                      XML     13K 
 8: XML         XBRL Instance -- cdlx-20221118_htm                   XML     22K 
 4: EX-101.DEF  XBRL Definitions -- cdlx-20221118_def                XML     38K 
 5: EX-101.LAB  XBRL Labels -- cdlx-20221118_lab                     XML     79K 
 6: EX-101.PRE  XBRL Presentations -- cdlx-20221118_pre              XML     38K 
 3: EX-101.SCH  XBRL Schema -- cdlx-20221118                         XSD     12K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               13±    19K 
11: ZIP         XBRL Zipped Folder -- 0001666071-22-000155-xbrl      Zip    209K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C: 
  cdlx-20221118  
 i 0001666071 i false00016660712022-11-182022-11-18

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM  i 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):  i November 18, 2022
 
cdlx-20221118_g1.jpg
 i CARDLYTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
 i Delaware i 001-38386 i 26-3039436
(State or other jurisdiction of
incorporation or organization)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 i 675 Ponce de Leon Avenue NE, Suite 6000 i Atlanta i Georgia i 30308
(Address of principal executive offices, including zip code)
 i (888) i 798-5802
(Registrant's telephone, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 i Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of each classTrading symbolName of each exchange on which registered
 i Common Stock i CDLX i The Nasdaq Stock Market LLC
 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  



ITEM 8.01    OTHER EVENTS
This current report on Form 8-K is being filed solely to file a corrected version of Agreement and Plan of Merger, dated April 12, 2021, by and among Cardlytics, Inc., Bridg, Inc., Mr. T Merger Sub, Inc., and Shareholder Representative Services LLC (the “Agreement”) as Exhibit 10.1. The version of the Agreement previously filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on August 3, 2021 contained certain formatting errors, which have been corrected in the attached Exhibit 10.1, which is incorporated herein by reference.
ITEM 9.01    FINANCIAL STATEMENTS AND EXHIBITS
(d)    Exhibits
Exhibit  Exhibit Description
10.1^
^ Certain portions of this exhibit, indicated by asterisks, have been omitted pursuant to Item 601(b)(10) of Regulation S–K because they are not material and would likely cause competitive harm to the registrant if publicly disclosed.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 Cardlytics, Inc.
   
Date:November 18, 2022By:/s/ Andrew Christiansen
  Andrew Christiansen
  
Chief Financial Officer
(Principal Financial and Accounting Officer)



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:11/18/22
8/3/2110-Q,  4,  8-K,  S-8
4/12/214,  8-K
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/14/24  Cardlytics, Inc.                  10-K       12/31/23   93:10M
 3/01/23  Cardlytics, Inc.                  10-K       12/31/22   94:12M
 3/01/23  Cardlytics, Inc.                  POSASR      3/01/23    6:711K
Top
Filing Submission 0001666071-22-000155   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 25, 6:49:56.1pm ET